Edward J. Kelly

5.1k total citations
96 papers, 3.5k citations indexed

About

Edward J. Kelly is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Edward J. Kelly has authored 96 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Pharmacology and 21 papers in Oncology. Recurrent topics in Edward J. Kelly's work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (17 papers) and 3D Printing in Biomedical Research (12 papers). Edward J. Kelly is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (17 papers) and 3D Printing in Biomedical Research (12 papers). Edward J. Kelly collaborates with scholars based in United States, United Kingdom and Ireland. Edward J. Kelly's co-authors include Richard D. Palmiter, Allan E. Rettie, Jonathan Himmelfarb, Mariko Nakano, Jonathan D. Gitlin, Aimee Payne, Carol J. Quaife, Catherine K. Yeung, Elijah J. Weber and Glenda J. Froelick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Edward J. Kelly

93 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward J. Kelly United States 35 1.1k 643 621 591 556 96 3.5k
Peter Olinga Netherlands 41 1.3k 1.2× 1.0k 1.6× 510 0.8× 166 0.3× 828 1.5× 175 5.4k
Xinwen Wang China 38 1.7k 1.5× 448 0.7× 398 0.6× 229 0.4× 381 0.7× 154 4.6k
Aree Moon South Korea 42 2.8k 2.5× 1.4k 2.1× 313 0.5× 139 0.2× 430 0.8× 126 5.5k
Bin Bao United States 41 3.5k 3.1× 1.4k 2.2× 249 0.4× 1.4k 2.4× 109 0.2× 84 6.5k
Zhibo Gai China 31 1.3k 1.1× 465 0.7× 681 1.1× 182 0.3× 208 0.4× 72 3.3k
Ji‐Ye Yin China 41 2.7k 2.5× 1.1k 1.7× 370 0.6× 155 0.3× 343 0.6× 197 5.1k
Gary Gordon United States 35 1.4k 1.3× 1.0k 1.6× 253 0.4× 84 0.1× 294 0.5× 105 4.4k
Pauline de la Μ. Hall Australia 35 1.0k 0.9× 375 0.6× 105 0.2× 284 0.5× 608 1.1× 121 5.3k
Bei Sun China 37 3.7k 3.3× 1.1k 1.7× 248 0.4× 269 0.5× 196 0.4× 160 6.8k
Masuhiro Nishimura Japan 28 1.0k 0.9× 996 1.5× 98 0.2× 232 0.4× 879 1.6× 92 3.4k

Countries citing papers authored by Edward J. Kelly

Since Specialization
Citations

This map shows the geographic impact of Edward J. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Kelly more than expected).

Fields of papers citing papers by Edward J. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Kelly. The network helps show where Edward J. Kelly may publish in the future.

Co-authorship network of co-authors of Edward J. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Kelly. A scholar is included among the top collaborators of Edward J. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Kelly. Edward J. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicholson, Tristan M., et al.. (2025). In vitro models of the male reproductive system: applications for developmental and reproductive toxicology. Toxicological Sciences. 208(2). 188–206.
2.
Lidberg, Kevin A., et al.. (2024). Development of a kidney microphysiological system hardware platform for microgravity studies. npj Microgravity. 10(1). 54–54. 1 indexed citations
3.
Lidberg, Kevin A., Lu Wang, James W. MacDonald, et al.. (2024). Modeling cellular responses to serum and vitamin D in microgravity using a human kidney microphysiological system. npj Microgravity. 10(1). 75–75. 1 indexed citations
4.
MacDonald, James W., et al.. (2024). Human enteroid monolayers: A novel, functionally stable model for investigating oral drug disposition. Drug Metabolism and Disposition. 53(1). 100002–100002. 6 indexed citations
5.
Chang, Shih‐Yu, Weize Huang, Alenka Chapron, et al.. (2023). Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease. Pharmaceutical Research. 40(11). 2597–2606. 6 indexed citations
6.
Hagenbuch, Bruno, et al.. (2023). Molecular Mechanisms of Organic Anion Transporting Polypeptide–Mediated Organic Anion Clearance at the Blood–Cerebrospinal Fluid Barrier. Molecular Pharmacology. 104(6). 255–265. 2 indexed citations
7.
Lidberg, Kevin A., Mohamed Adil, Lu Wang, et al.. (2022). Serum Protein Exposure Activates a Core Regulatory Program Driving Human Proximal Tubule Injury. Journal of the American Society of Nephrology. 33(5). 949–965. 14 indexed citations
8.
Kelly, Edward J., et al.. (2022). Optimal Timing of Cholecystectomy for Acute Cholecystitis: A Retrospective Cohort Study. Cureus. 14(8). e28548–e28548. 2 indexed citations
9.
Imaoka, Tomoki, et al.. (2021). Gutsy science: In vitro systems of the human intestine to model oral drug disposition. Pharmacology & Therapeutics. 230. 107962–107962. 18 indexed citations
10.
Imaoka, Tomoki, Weize Huang, Sara Shum, et al.. (2021). Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system. Scientific Reports. 11(1). 21356–21356. 21 indexed citations
11.
Weber, Elijah J., Kevin A. Lidberg, Lu Wang, et al.. (2018). Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight. 3(24). 70 indexed citations
12.
Chang, Shih‐Yu, Elijah J. Weber, Viktoriya S. Sidorenko, et al.. (2017). Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2(22). 138 indexed citations
13.
Adler, Melanie, Susanne Ramm, Marc Hafner, et al.. (2015). A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. Journal of the American Society of Nephrology. 27(4). 1015–1028. 95 indexed citations
14.
Risler, Linda J., Bhagwat Prasad, Justina C. Calamia, et al.. (2014). Identification of CYP3A7 for glyburide metabolism in human fetal livers. Biochemical Pharmacology. 92(4). 690–700. 32 indexed citations
15.
Lee, Nora, Mary F. Hébert, Bhagwat Prasad, et al.. (2013). Effect of Gestational Age on mRNA and Protein Expression of Polyspecific Organic Cation Transporters during Pregnancy. Drug Metabolism and Disposition. 41(12). 2225–2232. 54 indexed citations
16.
McConnachie, Lisa A., Miklós Bodor, Brian Phillips, et al.. (2004). An RT-PCR-based Strategy to Estimate Full-Length CYP2D6 mRNA Copy Number. Genetic Testing. 8(3). 313–318. 3 indexed citations
17.
Marrs, Richard P., David R. Meldrum, S.J. Muasher, et al.. (2004). Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online. 8(2). 175–182. 121 indexed citations
18.
McGarrity, Thomas J., Francesca Ruggiero, William Y. Chey, et al.. (2000). Giant Fundic Polyp Complicating Attenuated Familial Adenomatous Polyposis. The American Journal of Gastroenterology. 95(7). 1824–1828. 4 indexed citations
19.
Erickson, Jay C., Brian A. Masters, Edward J. Kelly, Ralph L. Brinster, & Richard D. Palmiter. (1995). Expression of human metallothionein-III in transgenic mice. Neurochemistry International. 27(1). 35–41. 43 indexed citations
20.
Lobo, Errol, Fred Elfman, Edward J. Kelly, & H. Daniel Perez. (1990). Effect of phorbol myristate acetate on processing of formyl peptide receptors by human neutrophils. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1055(2). 193–196. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Olinga Breakdown of academic impact, for papers by Xinwen Wang Breakdown of academic impact, for papers by Aree Moon Breakdown of academic impact, for papers by Bin Bao Breakdown of academic impact, for papers by Zhibo Gai Breakdown of academic impact, for papers by Ji‐Ye Yin Breakdown of academic impact, for papers by Gary Gordon Breakdown of academic impact, for papers by Pauline de la Μ. Hall Breakdown of academic impact, for papers by Bei Sun Breakdown of academic impact, for papers by Masuhiro Nishimura
Rankless by CCL
2026